Taysha Gene Therapies, Inc. Annual Interest Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Taysha Gene Therapies, Inc. quarterly/annual Interest Expense history and growth rate from 2020 to 2023.
  • Taysha Gene Therapies, Inc. Interest Expense for the quarter ending June 30, 2024 was $27K, a 98.1% decline year-over-year.
  • Taysha Gene Therapies, Inc. Interest Expense for the twelve months ending June 30, 2024 was $2.24M, a 56.9% decline year-over-year.
  • Taysha Gene Therapies, Inc. annual Interest Expense for 2023 was $5M, a 31.6% increase from 2022.
  • Taysha Gene Therapies, Inc. annual Interest Expense for 2022 was $3.8M, a 166% increase from 2021.
  • Taysha Gene Therapies, Inc. annual Interest Expense for 2021 was $1.43M, a 5000% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5M +$1.2M +31.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $3.8M +$2.37M +166% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $1.43M +$1.4M +5000% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $28K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.